Charles River Laboratories
407 hedge funds and large institutions have $5.16B invested in Charles River Laboratories in 2018 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 117 increasing their positions, 155 reducing their positions, and 32 closing their positions.
215% more call options, than puts
Call options by funds: $18.3M | Put options by funds: $5.82M
141% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 32
11% more funds holding
Funds holding: 366 → 407 (+41)
2.02% less ownership
Funds ownership: 97.11% → 95.09% (-2%)
18% less capital invested
Capital invested by funds: $6.27B → $5.16B (-$1.11B)
25% less repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 155
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Epoch Investment Partners
New York
|
+$43.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$38.5M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$30.1M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$29.4M |
| 5 |
Millennium Management
New York
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$96.6M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$40.5M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$33.3M |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$30.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SPIA
426
Steward Partners Investment Advisory
New York
| – | -$63K | -469 | Closed |
|
427
Simplex Trading
Chicago,
Illinois
| – | -$25K | -200 | Closed |
|
|
MWPCG
428
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
| – | -$24K | -170 | Closed |
|
|
MCM
429
Monument Capital Management
Alexandria,
Virginia
| – | -$20K | -150 | Closed |
|
|
WC
430
Whitney & Co
Rochester,
New York
| – | -$20K | -150 | Closed |
|
|
KJWM
431
Kiley Juergens Wealth Management
Olympia,
Washington
| – | -$19K | -143 | Closed |
|
|
AIL
432
AGF Investments LLC
Toronto,
Ontario, Canada
| – | -$10K | -78 | Closed |
|
|
MCM
433
MV Capital Management
Bethesda,
Maryland
| – | -$6K | -45 | Closed |
|
|
SFSIG
434
San Francisco Sentry Investment Group
San Francisco,
California
| – | -$4K | -29 | Closed |
|
|
APP
435
Avantax Planning Partners
Dubuque,
Iowa
| – | -$3K | -25 | Closed |
|
|
TPWA
436
TRUE Private Wealth Advisors
Salem,
Oregon
| – | -$3.23K | -24 | Closed |
|
|
FCA
437
FinTrust Capital Advisors
Greenville,
South Carolina
| – | +$125 | +1 | New |
|
438
AssetMark Inc
Concord,
California
| – | +$501 | +4 | New |
|
CRL Hedge Fund Activity: Q4 2018 in Review
407 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2018, worth a combined $5.16B — down 18% from $6.27B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new CRL positions and 32 closed out — a net gain of 45 holders — while 117 added to existing stakes and 155 trimmed.
The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $43.1M. The largest seller was Fidelity International, cutting an estimated $96.6M.
- 407 institutional investors held Charles River Laboratories (CRL) as of Q4 2018, up from 366 in Q3 2018.
- Funds reported $5.16B of Charles River Laboratories stock for Q4 2018, down 18% quarter-over-quarter.
- 77 funds opened new Charles River Laboratories positions in Q4 2018 and 32 closed out, a net change of +45 holders.
- The largest Charles River Laboratories buyer in Q4 2018 was Epoch Investment Partners, an estimated $43.1M added.
- The largest Charles River Laboratories seller in Q4 2018 was Fidelity International, an estimated $96.6M sold.
Based on aggregated 13F filings for Q4 2018.